
Biopeak opens flagship Bengaluru clinic
By Abha Lohia · Editor ·
Biopeak: valuation and funding and every story →
BengaluruFounded 2024
- Biopeak operates clinics offering advanced diagnostics and regenerative therapies for longevity
- The company opened its flagship Indiranagar centre as its first location in April 2025
- It aims to break even within 18 months and expand to at least two more sites
What happened
- Biopeak launched a 14,500 sq. ft. flagship clinic in Indiranagar, Bengaluru.
- This marks the opening of the company's second operational centre as of August 2026.
- The first clinic was opened in April 2025 to begin operations.
- The new facility focuses on advanced diagnostics and regenerative therapies for patients.
- Biopeak plans to open at least two more clinics during the current financial year.
- The company is currently in discussions for a next fundraise at a higher valuation.
- Management expects each clinic to reach break-even within 12-18 months.
- The firm targets older individuals now but aims to attract those in their late 20s.
Why it matters
- The strategy relies on a hardware-agnostic model rather than proprietary wearables.
- Future growth targets include markets like Singapore and Dubai with Indian diaspora.
The business
- Biopeak provides personalised preventive care and nutrition-focused interventions to clients.
- Its flagship clinic combines advanced diagnostics, regenerative therapies, and personalised preventive care.
- The team includes doctors, nutritionists, physiologists, and genetic scientists.
- Services are outcome-driven and integrate data from multiple consumer gadgets.
- The company does not plan to manufacture its own proprietary wearable devices.
- Current demand comes largely from older individuals seeking health optimization.
- The business model targets long-term expansion into United States markets.
The founders
In numbers
two centresClinics operating · 2026
₹50 crorePost-money valuation
12-18 monthsBreak-even timeline
What happens next
- Open at least two more clinics during the current financial year.
- Raise funds at a higher valuation than the current ₹50 crore mark.
- Expand geographically to Singapore, Dubai, and the United States eventually.
Words to know
- Regenerative therapies
- Treatments that aim to restore function by replacing or regenerating human cells.
- Hardware-agnostic
- A system that works with any device brand rather than requiring specific hardware.
The numbers around it
Biopeak has 1 funding rounds in StopDown's archive, $2.7M raised in all.
| When | Round | Amount | Led by |
|---|---|---|---|
| 2 February 2026 | seed | $2.7M | Nikhil Kamath |
Healthcare & Life Sciences in August 2026: 10 rounds with a disclosed amount, $139 million in all; the biggest was Biodeal Pharmaceuticals (₹385 crore). Every sector this year →
Terms in this story
- Profitability: A path to profitability is the plan and evidence that a startup will earn more than it spends. In India the usual order is contribution positive, then EBITDA positive, then net profit and positive cash flow. Each step is a different test, so claims of profit need the definition.
Read next
FundingAugust AI raises $12M for US expansionAugust AI offers an AI health assistant that answers medical questions through WhatsApp and a mobile appFundingVitusCare raises $3 million Series BVitusCare runs dialysis units inside partner hospitals, which keeps costs low, and has grown from 22 to over 60 centresLaunchKapiva gives away Dia Free Juice on World Diabetes DayKapiva is a Bengaluru-based Ayurveda wellness brand selling herbal juices and supplements, with a flagship juice aimed at people managing blood sugar
Everything on Biopeak → · All startup news on 7 August 2026 →
Is this Biopeak? Get your “Featured on StopDown” badge →